Berberine SAP
This product contains berberine hydrochloride, which is claimed to potentially treat metabolic syndrome and reduce symptoms of nonalcoholic fatty liver disease (NAFLD). It also shows antidiabetic and lipid-lowering effects.
- The description claims berberine may be a potential treatment for metabolic syndrome.
- The description claims berberine can reduce symptoms associated with nonalcoholic fatty liver disease (NAFLD).
- The description claims berberine has antidiabetic effects and lipid-lowering capability.
AI Readiness
Good foundation, but some important product data is still missing.
79%